StopDown
Cent logo
Funding · 31 March 2026Cent$5 MnPreventive healthcare intelligence platformcentralbank.bank.in ↗

Cent raises $5 Mn seed for early disease detection

By · Editor ·

seedFounded 2025
  • Cent uses precision radiology and blood tests to detect life-threatening diseases before symptoms appear
  • The company raised a $5 Mn seed round from OneFlow Holdings and South Park Commons, and exited stealth on 31 March 2026
  • Cent has completed 1,500 scans, with 4% revealing critical conditions, and plans to expand to three cities from April 2026

What happened

  • Cent, a preventive healthcare startup, launched on 31 March 2026 after coming out of stealth mode.
  • The company raised a $5 Mn seed round from OneFlow Holdings and South Park Commons.
  • Cent was founded by Shashank ND, cofounder of Practo, along with Anshul Khandelwal and Arpit Garg.
  • The startup uses precision radiology and blood biomarkers to detect life-threatening diseases before symptoms appear.
  • Cent has been operational since the beginning of FY2026-27 and has completed 1,500 scans.
  • The company reported that 26% of scans found relevant clinical findings, and 4% found critical conditions.
  • Cent's annualised revenue run rate is approximately $2 Mn, with 50% month-on-month growth.
  • The startup plans to open centres in Mumbai, Delhi, and Bengaluru from April 2026, with Pune and Hyderabad later.

Why it matters

  • Cent enters a growing market of preventive healthtech, with competitors like Biopeak also focusing on early detection.
  • Biopeak raised $2.7 Mn in January 2026 to scale its clinic network, showing investor interest in this space.
  • The startup's focus on detecting cancer, cardiac, neurological, and metabolic risks addresses a major healthcare gap.
  • Cent's early traction, with 1,500 scans and 4% critical findings, highlights the potential impact of early detection.
  • The founders' experience, especially Shashank ND's role at Practo, adds credibility to the venture.

The business

  • Cent is a direct-to-consumer preventive healthcare intelligence platform.
  • The company offers a diagnostic protocol including whole-body MRI, low-dose CT, DEXA scans, ECG, and 120+ blood and urine biomarkers.
  • Cent uses AI-powered synthesis to analyse data and detect risks for cancer, cardiac, neurological, and metabolic conditions.
  • The platform screens for 300+ conditions in a single visit, with faster scan times.
  • Each assessment is followed by a clinical consultation.
  • Cent operates single-purpose centres with a single workflow for disease detection.
  • The company generates revenue from its diagnostic services, with an annualised run rate of about $2 Mn.
  • Cent aims to help people live over 100 years by detecting diseases early.

The founders

Shashank ND

Cofounder and CEO
  • Cofounder and CEO of Cent.
  • Cofounder and CEO of Practo, a healthcare platform.
  • His family office, OneFlow Holdings, invested in Cent's seed round.

Anshul Khandelwal

Cofounder
  • Cofounder of Cent.
  • Former Chief Marketing Officer at Ola, a ride-hailing company.

Arpit Garg

Cofounder
  • Cofounder of Cent.
  • Sales veteran with experience in the industry.

Who put in money

  • OneFlow Holdings investor — Family office of Shashank ND, cofounder of Cent and Practo.
  • South Park Commons investor — An investment firm that participated in the seed round.

In numbers

$5 MnSeed funding amount · 2026
1,500Scans completed · 2026
26%Scans with relevant findings · 2026
4%Scans with critical conditions · 2026
50%Month-on-month growth · 2026
$2 MnAnnualised revenue run rate · 2026
5,000Projected scans by year-end · 2026

What happens next

  • Cent plans to build a network of single-purpose centres with a single workflow for CCNM detection.
  • The company will start rolling out centres in Mumbai, Delhi, and Bengaluru from April 2026.
  • Expansion to Pune and Hyderabad is planned for a later date.

Up against

Biopeak

Words to know

Seed funding
The first official round of financing for a startup, typically used to validate an idea and build a product.
Stealth mode
A strategy where a company keeps its operations and plans secret from competitors and the public until launch.
Annualised revenue run rate
An estimate of a company's future revenue over a year, based on current monthly or quarterly performance.
Biomarkers
Biological molecules in blood or other body fluids that indicate normal or abnormal processes, or disease.

The numbers around it

Cent has 2 funding rounds in StopDown's archive.

#The numbers around it
WhenRoundAmountLed by
27 October 2026Series A$15MBlume Ventures

Healthcare & Life Sciences in March 2026: 16 rounds with a disclosed amount, $134 million in all; the biggest was Cult.fit (₹440 Cr ($47.2 Mn)). Every sector this year →

Other articles talking about it

Read it as a card in the app

Terms in this story

  • Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
  • Seed round: Pre-seed and seed are the first money a startup raises from outside investors. The difference is how much has been built when the cheque arrives: pre-seed backs an idea or prototype, usually with a cheque under ₹5 crore, while seed backs an early product and runs from a few crore rupees to a few million dollars.

Everything on Cent → · All startup news on 31 March 2026 →

Is this Cent? Get your “Featured on StopDown” badge →